
CL Earnings
Colgate-Palmolive Co
- Overview
- Forecast
- Valuation
- Earnings
Earning Analysis
Welcome to our in-depth analysis of Colgate-Palmolive Co(CL) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of Colgate-Palmolive Co earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.
Earnings Forecast
Revenue
EPS
Currency: USD
Actual
Estimate
Surprise Analysis
FY2025Q2 | 2025-08-01 | Pre-Market | 0.89 | 0.92 | +3.37 | 5.05B | 5.11B | +1.19 | - | - |
FY2025Q1 | 2025-04-25 | Pre-Market | 0.86 | 0.91 | +5.81 | 4.86B | 4.91B | +0.98 | +1.31 | -0.55 |
FY2024Q4 | 2025-01-31 | Pre-Market | 0.89 | 0.91 | +2.25 | 4.99B | 4.94B | -0.89 | -4.61 | -5.73 |
FY2024Q3 | 2024-10-25 | Pre-Market | 0.88 | 0.91 | +3.41 | 5.01B | 5.03B | +0.54 | -4.14 | -6.05 |
FY2024Q2 | 2024-07-26 | - | 0.87 | 0.91 | +4.60 | 5.00B | 5.06B | +1.07 | +3.01 | +4.60 |
FY2024Q1 | 2024-04-26 | - | 0.82 | 0.86 | +4.88 | 4.96B | 5.07B | +2.14 | +1.93 | +4.05 |
FY2023Q4 | 2024-01-26 | - | 0.85 | 0.87 | +2.35 | 4.88B | 4.95B | +1.36 | +1.98 | +6.03 |
FY2023Q3 | 2023-10-27 | - | 0.80 | 0.86 | +7.50 | 4.82B | 4.92B | +2.07 | -1.77 | +2.35 |
FY2023Q2 | 2023-07-28 | - | 0.75 | 0.77 | +2.67 | 4.70B | 4.82B | +2.68 | -1.93 | -0.69 |
- | 2023-04-28 | - | 0.70 | 0.73 | +4.29 | - | - | - | +2.40 | +3.67 |
CL Earnings Analysis
Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, Colgate-Palmolive Co reported performance for FY2025Q2, announced on 2025-08-01. The company achieved an EPS of 0.92, compared to analyst estimates of 0.89 by 3.37% . Revenue for the quarter reached 5.11B compared to expectations of 5.05B by 1.19% .
The stock price reacted with a % one-day change and a % five-day change following the earnings release. These movements reflect market reaction in Colgate-Palmolive Co growth trajectory and strategic initiatives.
CL Earnings Forecast
Looking ahead, Colgate-Palmolive Co(CL) remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2025/Q2 project quarter revenue of 5.03B and an EPS of 0.90.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been Revise Upward by 0.2%, while EPS estimates have been Revise Upward by 0.71%. For the upcoming Q2 2025, revenue estimates have been adjusted Revise Upward by 0.08% . These revisions correlate with a -8.20% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in Colgate-Palmolive Co long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
Estimate Revision
The chart shows the correlation between CL's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
Revise Upward

+0.2%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward

+0.71%
In Past 3 Month
Revenue Estimates for Q2 2025
Revise Upward

+0.08%
In Past 3 Month
Stock Price
Go Down

-8.20%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:20.31B
--
EPS Estimate-Annual FY 2025:3.68
—
Stock Price83.25
CL Revenue and EPS Performance: A Historical Perspective
Colgate-Palmolive Co revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2025Q2 (2025-08-01,Pre-Market):
EPS: 0.92 (Actual) vs.0.89 (Estimate) (3.37%)
Revenue: 5.11B (Actual) vs. 5.05B (Estimate) (1.19%)
Price Reaction: %(1-Day), %(5-Day)
FY2025Q1 (2025-04-25,Pre-Market):
EPS: 0.91 (Actual) vs.0.86 (Estimate) (5.81%)
Revenue: 4.91B (Actual) vs. 4.86B (Estimate) (0.98%)
Price Reaction: 1.31%(1-Day), -0.55%(5-Day)
FY2024Q4 (2025-01-31,Pre-Market):
EPS: 0.91 (Actual) vs.0.89 (Estimate) (2.25%)
Revenue: 4.94B (Actual) vs. 4.99B (Estimate) (-0.89%)
Price Reaction: -4.61%(1-Day), -5.73%(5-Day)
Earnings Reaction
The chart below shows how CL performed 10 days before and after its earnings report, based on data from the past quarters. Typically, CL sees a -0.73% change in stock price 10 days leading up to the earnings, and a +0.91% change 10 days following the report. On the earnings day itself, the stock moves by -0.25%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in JUN/2025, the stock changed % on the day following the earnings release and then changed by 0% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Transcript Summary
Colgate-Palmolive Co (CL) Q2 2025 Earnings Call Summary
Positive
2025-08-01
The earnings call reflects a positive sentiment due to strong financial performance, product innovation, and a strategic focus on AI and data analytics. Despite some challenges, management's confidence in EPS growth and the relaunch of key products in multiple markets are positive indicators. The Q&A section highlights effective strategies to address market challenges, reinforcing the positive outlook. The company's commitment to shareholder returns and long-term growth further supports a positive sentiment.
Colgate-Palmolive Co (CL) Q1 2025 Earnings Call Summary
Neutral
2025-04-27
The earnings call presents a mixed picture. Financial performance shows an EPS increase, but tariffs and economic volatility pose challenges. Product development and market strategy highlight innovation and brand strength, but Q&A reveals concerns about North American market stability and unclear management responses on tariffs and consumer dynamics. Despite strong shareholder returns, uncertainties in guidance and economic factors balance out positives, leading to a neutral sentiment.
Colgate-Palmolive Co (CL) Q1 2025 Earnings Call Summary
Neutral
2025-04-25
The earnings call presents mixed signals: strong profit growth and a positive outlook for the latter half of the year are countered by significant risks like tariffs and consumer weakness. The Q&A highlighted management's optimism but also their vague responses to key challenges. The stock's reaction is likely muted due to the balance of positive and negative factors, resulting in a neutral sentiment.
Colgate-Palmolive Co (CL) Q1 2025 Earnings Call Summary
Negative
2025-04-25
The earnings call reveals several challenges: a negative 3% organic sales growth, significant $200 million tariff impact, and flat gross margins due to raw material inflation. While there are positive elements like strong Hill's sales and a robust balance sheet, the exit from private label products will negatively impact volume. The Q&A highlights management's lack of clarity on tariffs and private label impacts, adding uncertainty. Given these mixed signals and ongoing pressures, a negative stock price movement is likely over the next two weeks.
Colgate-Palmolive (CL) Q3 2024 Earnings Call Summary
Positive
2024-10-25
The earnings call reflects strong financial performance with mid-single-digit volume growth, gross margin expansion, and consistent EPS growth. Positive developments include strategic innovation, effective use of data, and strong cash flow for shareholder returns. Despite some concerns in North America, emerging markets and Europe show robust growth. Analysts' questions highlight confidence in management's strategy, with focus on innovation and premiumization. No major negative factors were identified, and the optimistic outlook for H2 and H3 supports a positive sentiment. However, the absence of guidance and some unclear responses prevent a stronger positive rating.
Colgate-Palmolive (CL) Q2 2024 Earnings Call Summary
Positive
2024-07-26
The earnings call summary indicates strong financial performance with expanding gross margins and consistent EPS growth. The company is committed to shareholder returns through dividends and share repurchases. Despite risks like competitive pressures and supply chain challenges, the Q&A section reflects confidence in volume growth and market share gains. Management's optimism and strategic initiatives suggest positive sentiment. However, some caution is warranted due to avoided questions on commodity costs. Overall, the positive aspects outweigh the negatives, leading to a positive stock price prediction over the next two weeks.
People Also Watch

TRI
Thomson Reuters Corp
201.210
USD
+0.15%

EMR
Emerson Electric Co
141.660
USD
-2.65%

BMO
Bank of Montreal
110.700
USD
+0.24%

NOC
Northrop Grumman Corp
585.040
USD
+1.46%

CP
Canadian Pacific Kansas City Ltd
72.820
USD
-0.99%

WMB
Williams Companies Inc
60.350
USD
+0.67%

FTNT
Fortinet Inc
97.350
USD
-2.55%

ET
Energy Transfer LP
17.790
USD
-1.39%

APD
Air Products and Chemicals Inc
282.040
USD
-2.03%

ORLY
O'Reilly Automotive Inc
98.840
USD
+0.53%
FAQ

What were the key highlights of CL’s latest earnings report for FY2025Q2?
CL reported its FY2025Q2 earnings on 2025-08-01, showcasing a revenue of 5.11B against an estimate of 5.05B, resulting in a 1.19% surprise. The EPS was 0.92, surpassing the expected 0.89 by 3.37% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

How did CL’s stock price react after the FY2025Q2 earnings release?

What are the revenue and EPS estimates for CL for 2025/Q2?

How does CL’s stock price correlate with earnings forecast revisions?

What should investors expect from CL’s next earnings report?
